New Technology Review: TAVR

The field of medicine is filled with transformational technologies that have radically altered disease treatment. From sterile techniques to blood transfusions, vaccines and antibiotics, medical technology continues to change our lives. A more recent development involves the treatment of valvular heart disease, which has been radically altered by the FDA’s approval of transcatheter aortic valve replacement (TAVR).

TAVR is an option for patients with severe aortic stenosis whose symptoms are inoperable or who are at high risk for standard surgical valve replacement. The first FDA approval of a TAVR device was in 2011 and the second came in 2014. The professional societies for cardiology and cardiac surgery worked together to develop the national Transcatheter Valve Therapy (TVT) registry for transcatheter valve patients. The first report from the registry was published in late 2013, with results for morbidity and mortality comparable to those outcomes during clinical trials. For more information on TAVR and other minimally invasive valve therapies, please access the Winter 2014 edition of The Source newsletter for Physician members of HealthTrust.

SourceTrust stays abreast of transformational technology in multiple specialties through review of clinical trial results in peer-reviewed journals and FDA postings. Up-to-date white papers are available to keep providers informed about the latest life-altering technologies.

Lynn Tarkington

Lynn Tarkington

Lynn Tarkington, RN, BS, is assistant vice president of Physician and Clinical Services at HealthTrust. She previously served as AVP of the clinical team for SourceTrust. Her background includes 30 years in the healthcare industry, with the focus of her clinical work in cardiovascular diseases. Tarkington previously worked with HCA in the corporate quality department, leading a team of professionals in improving cardiovascular quality across the organization. She is currently pursuing a master’s degree in public health and is a member of the American College of Cardiology, American Heart Association and the American College of Healthcare Executives.